↓ Skip to main content

Dove Medical Press

Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer

Overview of attention for article published in Drug Design, Development and Therapy, February 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

patent
1 patent

Readers on

mendeley
84 Mendeley
Title
Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer
Published in
Drug Design, Development and Therapy, February 2015
DOI 10.2147/dddt.s75152
Pubmed ID
Authors

Yi Qing, Qing Li, Tao Ren, Wei Xia, Yu Peng, Gao-Lei Liu, Hao Luo, Yu-Xin Yang, Xiao-Yan Dai, Shu-Feng Zhou, Dong Wang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 84 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 18%
Student > Ph. D. Student 13 15%
Student > Postgraduate 8 10%
Student > Master 8 10%
Researcher 6 7%
Other 13 15%
Unknown 21 25%
Readers by discipline Count As %
Medicine and Dentistry 28 33%
Biochemistry, Genetics and Molecular Biology 11 13%
Agricultural and Biological Sciences 5 6%
Neuroscience 4 5%
Immunology and Microbiology 3 4%
Other 3 4%
Unknown 30 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 February 2021.
All research outputs
#8,616,072
of 25,576,801 outputs
Outputs from Drug Design, Development and Therapy
#646
of 2,254 outputs
Outputs of similar age
#112,467
of 362,249 outputs
Outputs of similar age from Drug Design, Development and Therapy
#18
of 62 outputs
Altmetric has tracked 25,576,801 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,254 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,249 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.